Severity
Low
FDA Drug recall · Reported October 7, 2020
Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles.
Legacy Pharmaceutical Packaging LLC recalled Metformin Hydrochloride Tablets USP, 1000 mg, 60-count bottles, Rx Only, Manufactured fo… - a low-severity action.
Metformin Hydrochloride Tablets USP, 1000 mg, 60-count bottles, Rx Only, Manufactured fo… was recalled by Legacy Pharmaceutical Packaging LLC in October 7, 2020. Reason: Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles.. Check the official notice for the remedy. Verify recall #D-1626-2020 with the FDA Drug before acting.
The recall
Legacy Pharmaceutical Packaging LLC issued this low-severity FDA Drug recall-Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles..
Sourced from official FDA Drug enforcement records. Verify recall #D-1626-2020 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1626-2020) was formally reported on October 7, 2020, with the manufacturer initiating the action on September 24, 2020. It is classified under Low severity (Class III), with a current status of Terminated. Legacy Pharmaceutical Packaging LLC is listed as the recalling firm, operating out of Earth City, MO. Federal records list the affected scope as 111,948 bottles.
The documented reason for this recall is: Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles. Distribution data in the federal record shows the product reached: Walmart distribution centers in GA and AR. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
111,948 bottles
Related Recalls
6
5 from same agency
Metformin Hydrochloride Tablets USP, 1000 mg, 60-count bottles, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc., East Brunswick, NJ 08816, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, Distributed by: Wal-Mart, Bentonville, AR 72716. NDC 68645-545-59
Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-1626-2020 |
| Date reported | October 7, 2020 |
| Date initiated | September 24, 2020 |
| Recalling firm | Legacy Pharmaceutical Packaging LLC |
| Firm location | Earth City, MO |
| Affected scope | 111,948 bottles |
| Distribution | Walmart distribution centers in GA and AR |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported October 7, 2020. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.